Literature DB >> 8956012

Pathophysiology of vaso-occlusion.

S K Ballas1, N Mohandas.   

Abstract

Sickle cell anemia is a very complex disease. Vascular occlusion, the major event that accompanies SS, is itself a complex and multifactional process. Microvascular occlusion results in acute painful crises, whereas macrovascular occlusion seems to be the cause of organ failure. Understanding the basic pathophysiologic events of vascular occlusion may elucidate the clinical manifestations of SS, its natural history, and complications, and it may give new insights into preventive and curative therapy.

Entities:  

Mesh:

Year:  1996        PMID: 8956012     DOI: 10.1016/s0889-8588(05)70396-8

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  14 in total

1.  Epinephrine modulates BCAM/Lu and ICAM-4 expression on the sickle cell trait red blood cell membrane.

Authors:  Jamie L Maciaszek; Biree Andemariam; Greg Huber; George Lykotrafitis
Journal:  Biophys J       Date:  2012-03-06       Impact factor: 4.033

2.  AKAP-dependent modulation of BCAM/Lu adhesion on normal and sickle cell disease RBCs revealed by force nanoscopy.

Authors:  Jamie L Maciaszek; Biree Andemariam; Krithika Abiraman; George Lykotrafitis
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

3.  Cell rigidity and shape override CD47's "self"-signaling in phagocytosis by hyperactivating myosin-II.

Authors:  Nisha G Sosale; Tahereh Rouhiparkouhi; Andrew M Bradshaw; Rumiana Dimova; Reinhard Lipowsky; Dennis E Discher
Journal:  Blood       Date:  2014-11-19       Impact factor: 22.113

4.  Pattern of serum cytokine expression and T-cell subsets in sickle cell disease patients in vaso-occlusive crisis.

Authors:  Bolanle O P Musa; Geoffrey C Onyemelukwe; Joseph O Hambolu; Aisha I Mamman; Albarka H Isa
Journal:  Clin Vaccine Immunol       Date:  2010-02-03

5.  Application of machine learning in predicting blood flow and red cell distribution in capillary vessel networks.

Authors:  Saman Ebrahimi; Prosenjit Bagchi
Journal:  J R Soc Interface       Date:  2022-08-10       Impact factor: 4.293

6.  Treatment of homozygous sickle cell disease with pentoxifylline.

Authors:  A Sacerdote
Journal:  J Natl Med Assoc       Date:  1999-08       Impact factor: 1.798

7.  Evaluation of Longitudinal Pain Study in Sickle Cell Disease (ELIPSIS) by patient-reported outcomes, actigraphy, and biomarkers.

Authors:  Debra D Pittman; Patrick C Hines; David Beidler; Denis Rybin; Andrew L Frelinger; Alan D Michelson; Ke Liu; Xiufeng Gao; Jennell White; Ahmar U Zaidi; Robert J Charnigo; Michael U Callaghan
Journal:  Blood       Date:  2021-04-15       Impact factor: 22.113

8.  Sickle cell disease clinical phenotypes in Nigeria: A preliminary analysis of the Sickle Pan Africa Research Consortium Nigeria database.

Authors:  Hezekiah Isa; Samuel Adegoke; Anazoeze Madu; Abdul-Aziz Hassan; Chinatu Ohiaeri; Reuben Chianumba; Biobele Brown; Emmanuel Okocha; Ngozi Ugwu; Ijeoma Diaku-Akinwumi; Titilope Adeyemo; Aisha Kuliya-Gwarzo; Livingstone Dogara; Haliru Lawal; Yohanna Tanko; Adama Ladu; Umar Kangiwa; Lilian Ekwem; Seyi Oniyangi; Tambi Wakama; Domic Umoru; Olaniyi Olanrewaju; Norah Akinola; Uche Nnebe-Agumadu; Samuel Asala; Adekunle Adekile; John Olaniyi; Raphael Sangeda; Obiageli Nnodu
Journal:  Blood Cells Mol Dis       Date:  2020-04-23       Impact factor: 2.372

9.  Seroprevalence of parvovirus B19 antibodies and evidence of viremia among Nigerian patients with sickle cell anemia.

Authors:  Bamidele Abiodun Iwalokun; Senapon Olusola Iwalokun; Semande Olufunmilayo Hodonu
Journal:  J Biomed Res       Date:  2013-06-15

10.  CD47: A Cell Surface Glycoprotein Which Regulates Multiple Functions of Hematopoietic Cells in Health and Disease.

Authors:  Per-Arne Oldenborg
Journal:  ISRN Hematol       Date:  2013-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.